In Vivo Effects of Stroma-Free Hemoglobin and Polyhemoglobin on Coagulation Factors in Rats

Abstract

We studied the effects of rat stroma-free hemoglobin (rSFH), human stroma-free hemoglobin (hSFH), rat polyhemoglobin (rPoly), and human polyhemoglobin (hPoly) on coagulation factors in rats. Albumin and saline infused rats were controls. The infusion volume was 10% of the rat's blood volume. The concentrations of hemoglobin in this study were 7 g/dl.

Measurements for prothrombin time (PT) and activated partial thromboplastin time (PTT) were at 5 minutes, 2, 6, 24 and 72 hours after infusion. Factor X, fibrinogen, plasminogen, antithrombin III, and antiplasmin were followed at 24 and 72 hours after infusion. Compared with saline infused rats PT and PTT did not change significantly in those rats infused with Hb preparations. There was a transient increase of PTT from 2 to 24 hours after infusion in albumin infused rats. Factor X, fibrinogen, antithrombin III and antiplasmin showed no significant differences between Hb infused groups and saline infused group. Twenty-four hours and 72 hours after infusion plasminogen decreased in all groups except the albumin infused rats at 24 hours after infusion when compared with normal rat plasma pool. However, there were no significant differences in plasminogen levels between the hemoglobin infused groups and the control saline group.

Stroma-free and polyHb solutions (rSFH, hSFH, rPoly and hPoly) did not cause significant changes in prothrombin time and activated partial thromboplastin time in rats. The rats infused with hemoglobin solutions (rSFH, hSFH, rPoly, and hPloy) did not show significant differences in Factor X, fibrinogen, antithrombin III and antiplasmin levels compared with the control group.

Keywords

Stroma-free hemoglobin Polyhemoglobin Blood coagulation

Get full access to this article

View all access options for this article.

References

Chang

TMS

. Hemoglobin corpuscles. Report of a research project of B.Sc. Honours Physiology, McGill University, 1957.

Chang

TMS

. Semipermeable microcapsules. Science 1964; 146 (3643): 524.

Chang

TMS

. Aqueous semipermeable microcapsules as artificial cells. Ph.D. thesis, McGill University, Montreal, Canada, 1965.

Chang

TMS

. Artificial red cells. Trans Am Soc Artif Intern Organs 1980, 26: 354.

Chang

TMS

, Geyer

. Blood substitutes. New York and Basel: Marcel Dekker, Inc; 1989.

Keipert

, Minkowitz

, Chang

TMS

. Cross-linked stroma-free polyhemoglobin as potential blood substitute. Int J Artif Organs 1982; 5 (6): 383.

Keipert

, Chang

TMS

. In vivo assessment of pyridoxalated cross-linked polyhemoglobin as an artificial red cell substitute in rats. Trans Am Soc Artif Intern Organs 1983; 29: 329.

Keipert

, Chang

TMS

. Pyridoxalated polyhemoglobin as a blood substitute for resuscitation of lethal hemorrhagic shock in conscious rats. Biomat Med Dev Artif Org 1985; 13: 1–15.

Keipert

, Chang

TMS

. Effects of partial and total isovolemic exchange transfusion in fully conscious rats using pyridoxalated polyhemoglobin solution as a colloidal oxygen delivering blood replacement fluid. Vox Sang 1987; 53: 7–14.

10.

DeVenuto

, Zegna

. Blood exchange with pyridoxalated-polymerized hemoglobin. Surg Gynec Obst 1982; 155: 342.

11.

Sehgal

, Gould

, Rosen

, Sehgal

, Moss

. Polymerized pyridoxalated hemoglobin: a red cell substitute with normal oxygen capacity. Surgery 1984; 95 (4): 433.

12.

Gould

, Rosen

, Sehgal

, Moss

. Polymerized pyridoxalated hemoglobin: efficacy as an 02 carrier. The Journal of Trauma 1986; 26 (10): 903–8.

13.

Hobbhahn

, Vogel

, Kothe

, Brendel

, Keipert

, Jesch

Hemodynamics and transport after partial and total blood exchange with pyridoxalated polyhemoglobin in dogs. Acta Anaesth Scand 1985; 29: 537–43.

14.

Hertzman

, Keipert

, Chang

TMS

. Serum antibody titers in rats receiving repeated small subcutaneous injections of hemoglobin or polyhemoglobin: a preliminary report. Int J Artif Organs 1986; 9: 179–82.

15.

Chang

TMS

, Varma

Pyridoxalated heterogeneous and homologous polyhemoglobin and hemoglobin: systemic effects of replacement transfusion in rats previously received immunizing doses. Biomaterial, Artificial Cells and Artificial Organs 1987; 15 (2): 443–51.

16.

Chang

TMS

, Varma

Immunological and systemic effects of transfusions in rats using pyridoxalated hemoglobin and polyhemoglobin from homologous and heterogeneous sources. Biomaterial, Artificial Cells and Artificial Organs 1988; 16 (1-3): 205–15.

17.

Ning

, Chang

TMS

. Effects of stroma-free hemoglobin and polyhemoglobin on complement activation, blood cells and coagulation factors in rats. Biomaterial, Artificial Cells and Artificial Organs 1988; 16 (1-3): 651–2.

18.

Rabiner

, Friedman

. The role of intravascular hemolysis and the reticuloendothelial system in the production of a hypercoagulable state. Br J Haemat 1968; 14: 105.

19.

Spector

, Lang

, Crosby

. Coagulation changes in baboons during acute experimental hemoglobinemia and dextran infusion. Am J Pathol 1975; 78: 469.

20.

Savitsky

, Doczi

, Black

, Arnold

. A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 1978; 23: 73.

21.

Bolin

, Smith

, Moore

, Boswell

, DeVenuto

Hematological effect of hemoglobin solutions in animals. Progress in Clinical and Biological Research 1983; 122: 117–26.

22.

Feola

, Simoni

, Tran

, Canizaro

. Mechanisms of toxicity of hemoglobin solutions. Biomaterials, Artificial Cells and Artificial Organs 1988: 217–26.

23.

Keipert

, Chang

TMS

. Preparation and in vitro characteristics of pyridoxalated polyhemoglobin as blood substitute. Appl Biochem & Biotechnol 1984; 10: 133.

24.

Keipert

. Physiological effects of pyridoxalated polyhemoglobin as a blood substitute in rats. Ph.D. thesis, McGill University, 1985.

25.

Owen

, Bowie

EJW

, Thompson

FJH

. The diagnosis of bleeding disorders. Boston: Little, Brown and Company, 1975.

26.

Bergstom

, Egberg

Determination of vitamin K sensitive coagulation factors in plasma. Studies on three methods using synthetic chromogenic substrates. Thromb Res 1978; 12: 531–47.

27.

Bang

, Beller

, Beulsch

Thrombosis and bleeding disorders. New York: Academic Press, 1971; 232.

28.

Friberger

Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and plasma kallikreinkinin systems. Scand J Clin Lab Invest 1982; 162 (suppl): 49–54.

29.

Abildgaard

, Lie

, Odegegard

. Antithrombin (heparin cofactor) assay with new chromogenic substrates. Thromb Res 1977; 11: 549–53.

30.

Friberger

Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikreinkinin systems. Scand J Clin Lab Invest 1982; 162 (suppl): 42–7.